Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Labomar Canada Inc | Pointe-Claire, Canada | Makes it | No problems foundAug 9, 2024 · 6 inspections |
Recalls
- Apr 20, 2026 · Class II · Acella Pharmaceuticals, LLC
Chemical contamination; presence of lead and lithium above specification
Lots: Lot: 23F02, Expires: 05/2026; 25A37, Expires: 01/2028.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Naproxen: every company that makes it
- Form
- suspension, oral
- Strength
- 125 mg per 5 mL
- Approval
- NDA authorized generic NDA018965
- On the market since
- Nov 12, 2020
- Package NDCs
42192-619-16- Official label
- DailyMed (National Library of Medicine), updated Jan 5, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?